Natrol0.1%

Natrol is a topical nasal decongestant indicated for:

• Established/approved use: Temporary relief of nasal congestion associated with the common cold, upper respiratory tract infections, allergic rhinitis (hay fever), and sinusitis.
• Adjunct use: Shrinking swollen nasal mucosa to help nasal secretions drain (e.g., in sinusitis) and as an adjunct before rhinoscopy or other nasal examinations to improve visualization.

Natrol is intended only for short-term, temporary symptomatic relief and does not treat the underlying cause of congestion.

Xylometazoline Hydrochloride nasal drops/spray is available in two common strengths:

• Pediatric strength: Xylometazoline Hydrochloride 0.5 mg/mL (0.05% w/v)
• Adult strength: Xylometazoline Hydrochloride 1 mg/mL (0.1% w/v)

Formulations may also contain preservatives (e.g., benzalkonium chloride), buffering and isotonic agents, and purified water; the exact excipients vary by brand and dosage form (drops, spray, or gel), so the specific product label should be consulted.

Natrol is a topical, direct-acting alpha-adrenergic agonist belonging to the imidazoline chemical class. Applied to the nasal mucosa as drops or a metered spray, it produces localized vasoconstriction of the small blood vessels lining the nasal passages, which reduces mucosal swelling and congestion and allows easier breathing.

Natrol is available over-the-counter (in most markets) in pediatric (0.05%) and adult (0.1%) concentrations, with onset of action typically within minutes and effect lasting several hours. It is intended strictly for short-term symptomatic use.

Natrol belongs to the therapeutic class of topical nasal decongestants (sympathomimetic/adrenergic agonists), specifically the imidazoline derivative subclass, which also includes agents such as oxymetazoline and naphazoline.

Mechanism of Action

Xylometazoline Hydrochloride is a direct-acting agonist at alpha-1 (and to some extent alpha-2) adrenergic receptors located on the smooth muscle of nasal mucosal arterioles. Stimulation of these receptors causes local vasoconstriction, which reduces blood flow and fluid leakage into nasal tissue, thereby decreasing mucosal edema and nasal airway resistance and improving nasal airflow.

Pharmacokinetics

When used intranasally at recommended doses, systemic absorption of Xylometazoline Hydrochloride is generally low; however, absorption increases with excessive dosing, prolonged use, or use in young children, which can lead to systemic sympathomimetic effects. Onset of decongestant action typically occurs within 5-10 minutes and may last up to 10 hours, depending on the formulation.

Natrol is for intranasal (nasal) use only.

• Blow the nose gently to clear nasal passages before use.
• Tilt the head slightly forward or keep it upright (per product instructions) and insert the tip into one nostril.
• Spray or instill the drops while breathing in gently through the nose; avoid tilting the head far back.
• Wipe the nozzle after use and keep the container tightly closed.
• Do not share the bottle with other people, to avoid spreading infection.
• Avoid contact with the eyes; if accidental contact occurs, rinse with water.
• Do not use for longer than the recommended duration without consulting a physician (see Duration of Treatment).

Clinically significant interactions with Natrol include:

• Monoamine oxidase inhibitors (MAOIs): Concurrent use, or use within 14 days of an MAOI, can precipitate a hypertensive crisis due to additive sympathomimetic/pressor effects; this combination should be avoided (see Contraindications).
• Tricyclic antidepressants and other sympathomimetic agents (including other decongestants, e.g., oral pseudoephedrine/phenylephrine): May potentiate the pressor (blood pressure-raising) and cardiac stimulant effects of Natrol; concurrent use should be avoided or undertaken with medical supervision.
• Other topical nasal decongestants: Concomitant use of multiple nasal decongestant products increases the risk of systemic absorption and rebound congestion and is not recommended.

Side effects of Natrol are usually local and mild, but systemic effects can occur, particularly with overuse:

Common (local)

• Nasal or mucosal dryness, burning, or stinging
• Sneezing
• Rebound nasal congestion (rhinitis medicamentosa) with use beyond the recommended duration

Less common (systemic, more likely with overuse or in young children)

• Headache
• Palpitations, increased heart rate
• Increased blood pressure
• Nervousness, insomnia, dizziness
• Nausea

Pregnancy: Data on Natrol use in human pregnancy are limited. Because some systemic absorption can occur even with topical nasal use, Natrol should be used during pregnancy only if clearly needed, at the lowest effective dose, and for the shortest duration necessary; a physician should be consulted before use.

Lactation: It is not well established whether Natrol passes into breast milk in clinically significant amounts. Use with caution during breastfeeding, only if potential benefit justifies potential risk to the infant, and consult a physician before use.

• Rebound congestion: Using Natrol longer than the recommended duration (typically no more than about 5-7 consecutive days) can cause rebound congestion (rhinitis medicamentosa), where nasal stuffiness worsens once the medication wears off. Do not exceed the labeled frequency or duration.
• Accidental ingestion/poisoning risk in children: Concentrated pediatric and adult formulations of Natrol pose a recognized serious poisoning risk if accidentally ingested by young children, which can cause significant CNS and cardiovascular effects. Store the bottle securely, out of the sight and reach of children, and seek emergency care immediately if ingestion is suspected.
• Cardiovascular disease: Use with caution in patients with hypertension, coronary artery disease, or other cardiovascular conditions, as systemic sympathomimetic absorption (especially with overuse) can raise blood pressure and heart rate.
• Hyperthyroidism and diabetes mellitus: Use with caution, as sympathomimetic effects from systemic absorption may be more pronounced.
• Narrow-angle glaucoma: Use with caution due to potential systemic sympathomimetic effects with overuse; consult a physician if this condition is present.
• For nasal use only; avoid contact with the eyes.
• Natrol is not an antibiotic and does not treat bacterial infection; it only relieves congestion symptoms.

Overdose of Natrol, particularly from accidental ingestion by children or from excessive/prolonged nasal use, can cause systemic sympathomimetic toxicity, including headache, sweating, increased blood pressure, palpitations or irregular heartbeat, nausea, and nervousness. In young children, overdose can paradoxically also cause central nervous system depression, including drowsiness, low body temperature, slowed heart rate, and, in severe cases, coma.

If overdose or accidental ingestion is suspected, seek immediate medical attention or contact a poison control center/emergency services right away. Do not attempt specific home treatment; supportive care should be provided by medical professionals.

Store at room temperature (below 30°C), away from light and moisture. Keep the container tightly closed and out of reach of children.

Pediatric patients: Use only the strength and dose appropriate for the child's age, as labeled. Natrol is not recommended for children under 2 years old (safety and efficacy not established in this age group); use in older children should be supervised by an adult.

Elderly patients: Use with caution, particularly in those with cardiovascular disease, hypertension, or other conditions noted in Precautions and Warnings, as they may be more sensitive to systemic sympathomimetic effects.

Renal/hepatic impairment: Specific dose adjustment data are not well established for topical Natrol; because systemic absorption is normally low with appropriate short-term use, no specific adjustment is generally required, but caution is advised with prolonged or excessive use.

Natrol should be used only for short-term, temporary relief of nasal congestion. Continuous use should generally not exceed about 5-7 consecutive days, as longer use increases the risk of rebound congestion (rhinitis medicamentosa). If congestion persists beyond this period, a physician should be consulted rather than continuing self-treatment.

Nasal decongestant; imidazoline derivative; direct-acting alpha-adrenergic agonist (sympathomimetic)

Xylometazoline Hydrochloride directly stimulates alpha-adrenergic receptors on the smooth muscle of nasal mucosal blood vessels, producing local vasoconstriction. This reduces blood flow and fluid accumulation in the nasal mucosa, decreasing swelling and congestion and improving nasal airflow. (See Pharmacology for further detail.)

Natrol use in children should follow the age- and strength-specific labeling:

• Under 2 years: Not recommended; safety and efficacy have not been established in this age group.
• 2 to 12 years: Use only the pediatric strength (0.05%), at the lowest effective dose, under adult supervision, and for no longer than the recommended duration.
• Over 12 years: Adult strength (0.1%) may be used as per adult dosing.

Parents/caregivers should store Natrol securely, as accidental ingestion by young children is a recognized serious poisoning risk (see Precautions and Warnings and Overdose).